Clobetasone Butyrate Potency Classification
Clobetasone butyrate 0.05% is classified as a moderate potency (Class 4-5) topical corticosteroid.
Evidence-Based Classification
Multiple high-quality guidelines consistently categorize clobetasone butyrate as a moderate potency steroid:
UK Expert Consensus (2015): Explicitly lists clobetasone butyrate 0.05% (Eumovate®) under the "Moderate" potency category in their topical corticosteroid classification table 1
Comparative Potency Studies: Research demonstrates that clobetasone butyrate 0.05% has equivalent vasoconstrictive potency to betamethasone valerate 0.1% and beclomethasone dipropionate 0.025%, both established moderate potency steroids 2
Clinical Context
The moderate potency classification places clobetasone butyrate in the middle tier of the seven-class topical steroid hierarchy:
- Below it: Mild steroids like hydrocortisone 1% (Class 6-7)
- Above it: Potent steroids like betamethasone valerate 0.1% (Class 3) and very potent steroids like clobetasol propionate 0.05% (Class 1)
Important Clinical Distinctions
Do not confuse clobetasone butyrate with clobetasol propionate - these are entirely different molecules with vastly different potencies:
- Clobetasol propionate 0.05% = Very potent (Class 1)
- Clobetasone butyrate 0.05% = Moderate potency (Class 4-5)
Safety Profile
The moderate potency classification has practical implications for safety. Clinical trials involving over 3,500 patients demonstrate that clobetasone butyrate 0.05% has:
- Negligible systemic absorption even under extreme conditions
- Almost no effect on HPA axis function
- No clinically significant difference from hydrocortisone 1% in terms of skin thinning potential with short-term use 3
This favorable safety profile, combined with superior efficacy to hydrocortisone 1%, makes it appropriate for pharmacy-level (OTC) availability in some countries for short-term management of acute eczema and allergic dermatitis in adults and children aged 10 or older 3.